Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

More retinoids emerge from the Allergan pipeline

April 21, 1998

Sanofi discloses cGMP PDE inhibitors for cardiovascular indications

April 21, 1998

New water-soluble dolastatin derivatives with potent antitumor activity

April 21, 1998

Heterocyclic tachykinin antagonists from Sanofi

April 21, 1998

MS&D discovers agents for safely enhancing cognition

April 21, 1998

Synthelabo discloses new benzimidazoles for urinary incontinence

April 21, 1998

Tricyclic compounds inhibiting protein farnesyltransferase claimed by Schering-Plough

April 21, 1998

Conjugates for imaging vascular thrombi developed at NeoRx/U. of Washington

April 20, 1998

P&U claims new distamycin derivatives and their use as antitumor and antiviral agents

April 20, 1998

Chiesi prepares new anticonvulsants and neuroprotective agents

April 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...